Electroporation for the delivery of DNA-based vaccines and immunotherapeutics: current clinical developments
about
What you always needed to know about electroporation based DNA vaccinesAnti-angiogenic gene therapy in the treatment of malignant gliomasEnhancing the efficacy of cytotoxic agents for cancer therapy using photochemical internalisationMitigating the looming vaccine crisis: production and delivery of plasmid-based vaccinesLaser-induced microbubble poration of localized single cells.Efficient single-cell poration by microsecond laser pulses.Physically facilitating drug-delivery systems.Delivery of molecules into cells using carbon nanoparticles activated by femtosecond laser pulses.Cationic lipid-mediated delivery of proteins enables efficient protein-based genome editing in vitro and in vivoElectric pulses used in electrochemotherapy and electrogene therapy do not significantly change the expression profile of genes involved in the development of cancer in malignant melanoma cells.Novel vaccines to human rabiesEvaluation of a DNA Aβ42 vaccine in adult rhesus monkeys (Macaca mulatta): antibody kinetics and immune profile after intradermal immunization with full-length DNA Aβ42 trimer.Avoiding the side effects of electric current pulse application to electroporated cells in disposable small volume cuvettes assures good cell survivalImproving the DNA specificity and applicability of base editing through protein engineering and protein delivery.Electrically mediated delivery of plasmid DNA to the skin, using a multielectrode arrayImmunogenicity and efficacy of a plasmid DNA rabies vaccine incorporating Myd88 as a genetic adjuvant.Expression of dog microdystrophin in mouse and dog muscles by gene therapyDNA vaccination by intradermal electroporation induces long-lasting immune responses in rhesus macaques.Improvement of different vaccine delivery systems for cancer therapy.Broadly neutralizing DNA vaccine with specific mutation alters the antigenicity and sugar-binding activities of influenza hemagglutininEfficient electroporation of liposomes doped with pore stabilizing nisin.Genetic vaccination for re-establishing T-cell tolerance in type 1 diabetes.Transfection by electroporation.A lipocentric view of peptide-induced pores.Evaluation of delivery conditions for cutaneous plasmid electrotransfer using a multielectrode array.Current status of pharmaceutical and genetic therapeutic approaches to treat DMD.A DNA vaccine for venezuelan equine encephalitis virus delivered by intramuscular electroporation elicits high levels of neutralizing antibodies in multiple animal models and provides protective immunity to mice and nonhuman primates.Codon optimization of the human papillomavirus E7 oncogene induces a CD8+ T cell response to a cryptic epitope not harbored by wild-type E7Enhanced effect of DNA immunization plus in vivo electroporation with a combination of hepatitis B virus core-PreS1 and S-PreS1 plasmidsAdvances in Gene Delivery Systems.Muscle gene electrotransfer is increased by the antioxidant tempol in miceHIV DNA Vaccine: Stepwise Improvements Make a Difference.Dose-dependent inhibition of Gag cellular immunity by Env in SIV/HIV DNA vaccinated macaquesDNA is an efficient booster of dendritic cell-based vaccineA pilot study of pNGVL4a-CRT/E7(detox) for the treatment of patients with HPV16+ cervical intraepithelial neoplasia 2/3 (CIN2/3).Preclinical evaluation of the immunogenicity and safety of plasmid DNA-based prophylactic vaccines for human cytomegalovirus.DNA vaccines targeting human papillomavirus-associated diseases: progresses in animal and clinical studies.Deinococcus radiodurans pprI expression enhances the radioresistance of eukaryotes.Chimeric DNA Vaccines against ErbB2+ Carcinomas: From Mice to Humans.Emerging cancer vaccines: the promise of genetic vectors.
P2860
Q24602340-0DE5495A-8E89-4724-BCC1-3E5D11266722Q26866276-B6DB0800-FAFA-4896-B945-FE3999D65529Q26998547-AE0C32BD-997F-4763-9346-E7994B9EEE6AQ28294355-88BDB63E-37AD-4BAB-B17B-1F12A1228DD2Q30412532-0EF5ED2F-DDE3-463D-9E42-EC95BC6A5FC0Q30420426-04024399-5E37-475D-91C4-0B9F61E86120Q30462003-D1CACEF7-DAF2-4373-BEDB-072C2D173AFFQ30477374-572FDEC2-7D32-48BE-ADD5-659431E5CF6DQ30614255-EBE037A8-C6ED-472F-BEBF-57BA8A0658E0Q33497050-5E7F87F3-EF22-47D5-A3AF-CBD07BF32E2EQ33507253-51A56169-24DF-4497-B33E-FC56A287C4F4Q33604583-993D803C-A96B-4338-9A8B-320CCE4BB546Q33634886-F724F7E2-89BA-4FC9-BFF7-20E152A7BDFDQ33786397-EC3FF8A5-C82B-480D-A5FD-6366526E76C0Q33832131-C78353EB-0AD4-427F-B748-05C69EED6AEAQ33850502-BEBE80E8-D73B-4016-BEF5-12557094CBD0Q33931564-342EE518-8D6B-46DB-967A-4BF23BF210B4Q34250318-10DDC20F-D04D-4EC5-AB15-B573283CE25FQ34506877-B5143F69-9542-428C-BA43-70C6CFDA3173Q34621352-201AB359-2778-46B5-B79C-D3EB20B19D23Q34675279-EDAFDBA2-81B0-4FD4-BE5C-9F77B734B3FBQ34706913-105D7A70-E00E-4ECD-A010-D2DCB9B0C512Q34748879-53AF2F92-4474-4EF4-BCA3-9A7A6779F068Q34757093-9CA82A2E-B6E0-49D0-BC23-1B762159B983Q34977670-014F1D65-AFD3-48D3-9780-671521B16045Q34994545-363362C6-A380-4AE3-8893-CB7F7459ABBFQ35066196-8DDC31FA-5DB7-45D3-8496-ED0C975C8664Q35208290-2EBB116A-EB4E-466D-9C2A-E5579DEA5053Q35530249-123FE601-B9F6-430B-8048-F4EEC2305185Q35632772-4F80B75F-7045-46A9-A1B7-1A71FBDD1B62Q35819837-006D3C01-49AD-4C21-BB0E-6C0A22E644FFQ35826742-27BB9823-4367-4B4C-B9ED-316222B4A8BBQ36256319-FDB561D6-2FFE-458E-AEC3-25218365A415Q36256389-D2CFB838-40AD-4B3A-A3B3-F0FAD77BCDF2Q36494733-B74DCA79-EAD3-4083-A7CC-BB7C5751AC1CQ36694825-CEB4DF4B-F77C-457F-8BF1-45D336C5B533Q37010987-07A0BF47-8017-400C-96E4-DCCB64906C8EQ37085781-91719AFC-75B9-45A2-9BB7-CE2A41ED7037Q37137404-8131108F-A2EA-4732-BC80-2BBF370F3845Q37137464-503101B3-AF9E-4EE4-8DAC-46C36A28BAA3
P2860
Electroporation for the delivery of DNA-based vaccines and immunotherapeutics: current clinical developments
description
2009 nî lūn-bûn
@nan
2009 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Electroporation for the delive ...... current clinical developments
@ast
Electroporation for the delive ...... current clinical developments
@en
type
label
Electroporation for the delive ...... current clinical developments
@ast
Electroporation for the delive ...... current clinical developments
@en
prefLabel
Electroporation for the delive ...... current clinical developments
@ast
Electroporation for the delive ...... current clinical developments
@en
P2093
P2860
P356
P1433
P1476
Electroporation for the delive ...... current clinical developments
@en
P2093
Angela M Bodles-Brakhop
Richard Heller
Ruxandra Draghia-Akli
P2860
P304
P356
10.1038/MT.2009.5
P577
2009-02-17T00:00:00Z